Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients

NCT02414009 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Capecitabine
DRUG: Temozolomide
DRUG: Irinotecan
DRUG: Fluorouracil
DRUG: Leucovorin

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano